Skip to main content

Table 3 Natural history of select Angelman syndrome symptoms

From: Unmet clinical needs and burden in Angelman syndrome: a review of the literature

 

Infancy/Early Childhood

Middle Childhood/Adolescence

Adulthood

Current Standard of Care

Movement disorders

▪ Hypotonia/“floppy infant” observed in ~50% [6]

▪ Feeding issues/Poor suck in infancy [6, 8, 15, 16]

▪ All motor milestones delayed [24]

▪ Tone improves in most, but ~25% have persistent hypotonia and ~30% have hypertonia [6]

▪ Atypical or ataxic gait is common [10, 23, 25, 26]

▪ Coactivation of muscles, muscle weakness, and sensory-motor integration are also common [22]

▪ Developmental skills tend to plateau at 24–30 months [24]

▪ Oral motor challenges are also pervasive, with tongue thrusting, sucking and swallowing disorders, frequent drooling, excessive chewing, mouthing behaviors, and feeding difficulties reported in 20%–80% [8, 15, 16]

▪ Full toilet training obtained for about 30% of individuals with AS, although age of obtaining this milestone varies [8]

▪ NEM usually starts in adolescence [16, 28]

▪ Increase in scoliosis [8]

▪ Increases in tremor and NEM may result in loss of previous obtained skills [16, 28]

▪ Physical and occupational therapy [12]

▪ Physiotherapy [12]

▪ Bracing as needed [12]

▪ Increased activity and diet to prevent obesity [12]

Speech/Communication

▪ Less cooing and babbling in infancy [15]

▪ None or very little oral speech acquisition [35]

▪ No increases in verbal output [35]

▪ Development of gestures and other methods of communication [35, 36, 41, 42]

▪ Receptive language better than expressive [37, 45]

▪ No increases in verbal output [35]

▪ With improvement in attention span in adulthood, some increases in nonverbal communication [12]

▪ Communication challenges thought to contribute to aggression and anxiety [75]

▪ Augmentative and alternative communication systems [34, 44]

▪ Promotion and enhancement of natural gestures [46,47,48]

Behavior

Smiling/Laughing

▪ Early, persistent social smile reported as early as 1–3 months of age [50]

▪ More socially appropriate smiling/laughing [53]

▪ Decline in duration of smiling and laughing [54,55,56]

▪ Behavior-based interventions such as applied behavior analysis or discrimination training [77, 80,81,82]

▪ Increasing communication outputs [80]

▪ Psychopharmological treatment, including anxiolytic/anti-depressants (e.g., buspirone, guanfacine, clonidine); SSRIs (e.g., fluoxetine, sertraline, citalopram); antipsychotics (e.g., risperidone, aripiprazole, olanzapine); antihypnotic/stimulant (e.g., atomoxetine, methylphenidate, dexmethamphetamine) [16, 75]

Hyperactivity

▪ Hyperactivity reported to occur in nearly all young children with AS [15, 60]

▪ Hyperactivity/excitability the most prominent and severe behavior reported [13, 60]

▪ Hyperactivity decreases in adulthood [12, 60]

Aggression/Irritability

 

▪ Physical aggression has been reported in up to 73% of adolescents with AS [74]

▪ Physical aggression/irritability increase in adulthood [75]

Autism symptoms

 

▪ Comorbid autism diagnosis reported in up to 80% [62,63,64]

▪ Those with AS and comorbid ASD score lower on measures of language, adaptive behavior, and cognition, and have a slower rate of growth over time than those with AS without ASD [63]

 

Anxiety

  

▪ Anxiety increase in adulthood [75]

Other behaviors (e.g., repetitive behavior, mouthing)

  

▪ Self-injurious behaviors increase in adulthood [75]

Sleep

▪ Sleep issues peak between 2 and 9 years of age [84, 86]

▪ Sleep improves for some but sleep problems continue for a significant percentage [12, 75, 85,86,87]

▪ The most common type of sleep problem is insomnia with 35%–60% of individuals with AS being described as having difficulty initiating sleep and/or maintaining sleep and reduced total sleep time [61, 85, 87, 88]

▪ Quality of sleep is also problematic, with reduced sleep efficiency found via sleep polygraph in children with AS compared with controls [88, 89]

▪ Sleep improves for some, but sleep problems continue for up to 72% [12, 75, 85,86,87]

▪ Melatonin [93,94,95,96,97]

▪ Improvement of sleep environment [86, 87, 100]

▪ Adjusting sleep-wake schedules [94, 100]

▪ Reinforcing bedtime routines and independent sleep initiation [97, 100]

▪ Seizure medications [99, 116]

  1. AS Angelman syndrome, ASD autism spectrum disorder, NEM non-epileptic myoclonus, SSRI selective serotonin reuptake inhibitors